Vasopressors in sepsis: Do they change the outcome?

Marco A. González, Cristhiaan D. Ochoa

Resultado de la investigación: Capítulo del libro/informe/acta de congresoCapítulorevisión exhaustiva

Resumen

The final event in septic shock is multiorgan failure syndrome as a consequence of hypoperfusion resulting from a late, refractory vasodilatory shock. Before starting vasoactive agents, the underlying infectious disease must be under treatment, the volume status aggressively corrected, the immunomodulatory therapy started, and adrenal gland failure ruled out. NE is the vasoactive agent with the best results in refractory shock, and it is probably the vasoconstrictor that most improves mortality in septic patients. VP levels are depleted in the late phase of septic shock. If the patient is hypotensive, even though vasoactive agents and inotropes are used, VP should be started at low doses.

Idioma originalInglés
Título de la publicación alojadaSepsis (Second Edition)
EditorialSpringer New York
Páginas121-125
Número de páginas5
ISBN (versión impresa)0387298169, 9780387298160
DOI
EstadoPublicada - 2006
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Vasopressors in sepsis: Do they change the outcome?'. En conjunto forman una huella única.

Citar esto